Rephonic
Artwork for Flot.bio x Philip Hemme

Flot.bio x Philip Hemme

Flot.bio
Biotechnology
Clinical Trials
Biotech
Biopharma
Ulcerative Colitis
Rare Diseases
Drug Development
Abivax
Immunotherapy
Cell Therapy
Antibody-Drug Conjugates
EU Biotech
Cancer Vaccines
Venture Capital
Gene Therapy
Diversity In Biotech
Pharmaceutical Industry
Novo Holdings
Biotech Industry
Cardior

Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 25k monthly views. Free. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Niel... more

PublishesWeeklyEpisodes61Founded3 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Flot.bio x Philip Hemme

Latest Episodes

Christian Angermayer became a multimillionaire before turning 25 thanks to the merger of Alnylam with Ribopharma. We talk about his diverse investment appetite and the rise of consumer biotech and human enhancement.We talk about GLP-1s, the progress ... more

After ImCheck’s inception in 2015, Pierre took the helm through clinical development and guided the startup to a $1.2B buyout by Ipsen in 2025.

In a session at the Kadans Oncology Summit, he talks about how the exit materialised and the oncology spa... more

Founded in 2010, the Institut Pasteur spinout PathoQuest sold to top CRO Charles River for $70M this year, a product of years of collaboration and stepwise investments.Jean‑François tells us how the exit unfolded, as well as the importance of biosafe... more

When Hervé joined Incyte in 2014, the launch of lead product Jakafi in the US was choppy. By the time he left in 2025, he had grown their revenue from $300 million to a whopping $5 billion. We talk about the bureaucracy of Big Pharma, rare diseases, ... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Christian Angermayer
Billionaire investor focused on biotech, psychedelics, longevity, and consumer biotech
Apeiron
Episode: Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61
Pierre d'Epenoux
Founder/CEO of ImCheck (during the story)
ImCheck
Episode: ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech | Pierre d’Epenoux | E60
Jean-François Brepson
CEO, PathoQuest
PathoQuest
Episode: CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River | E59 [Sponsored]
Hervé Hoppenot
Former CEO of Incyte
Incyte
Episode: Ex-CEO of Incyte Hervé Hoppenot on 10x Growth, Biotech Cycles, and Breaking Bureaucracy | E58
Christoph Lengauer
Co-founder of Curie.Bio
Curie.Bio
Episode: Christoph Lengauer, Curie.Bio | Biotech Founders, Venture Capital | E57
Sander van Deventer
Co-founder of Forbion, prominent biotech investor
Forbion
Episode: Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Pedro (Immunethep)
Co-founder of Immunethep
Immunethep
Episode: Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
Bruno (Immunethep)
Co-founder of Immunethep
Immunethep
Episode: Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
António Portela
CEO of BIAL
BIAL
Episode: António Portela, Bial 🇵🇹 | Parkinson’s, Family-Owned Biotech | E54

Host

Philip Hemme
Host of Flot.bio Show

Reviews

4.6 out of 5 stars from 29 ratings
  • One of the best video podcasts for Biotech

    I’m one of the founders so I’m a bit biased. But if it try to listen to it as a user, I find it to be one of the best video podcasts, especially with Europeans speakers and mostly for a European audience. Would love to hear what you think

    Apple Podcasts
    5
    phm12345
    Germany3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Shows consistently highlights European biotech leaders and funding dynamics.
Guests are diverse but heavily industry leaders and investors, offering practical takeaways.
Listeners appreciate European-focused biotech insights and real-world founder stories.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech | Pierre d’Epenoux | E60
Q: What was the strategy that allowed ImCheck to pursue an exit over remaining independent?
The strategy combined strong data generation, a clear clinical path with phase transition planning (moving from phase one to seamless phase two/three), and building a capable team with investors willing to support a strategic exit when the right partner and timing aligned. External data supports were used to de-risk the pathway, and multiple funding rounds kept the company buoyant while preparing for the sale.
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
Q: What stages of product development are you currently pursuing and what are the regulatory implications?
The team moved from broad mechanism-based validation to family-specific formulations to simplify regulatory pathways, with emphasis on immunogenicity, safety in mice models, and GMP-scaleability to meet regulatory requirements.
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
Q: How does Immunethep's approach differ from traditional vaccines and antibiotics?
Immunethep focuses on restoring the immune system's ability to fight infection by neutralizing bacterial immunosuppression rather than just killing bacteria or targeting surface antigens, using a GAPDH-based mechanism to achieve broad coverage across multiple bacteria.
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
Q: What is the core problem AMR presents today, and why is it so urgent?
AMR represents a growing crisis where resistant bacteria render our current antibiotics ineffective, leading to higher mortality and healthcare costs; the urgency is driven by rising resistance, hospital infections, and the lack of new effective weapons in the arsenal.
Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Q: So how come you have unique technology and unique positioning?
It boils down to having efficient production and keeping costs out of production while adding value, which is key for negotiations with customers.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Flot.bio x Philip Hemme

What is Flot.bio x Philip Hemme about and what kind of topics does it cover?

A highly focused biotech-focused interview show that features founders, CEOs, and investment leaders discussing company-building, funding dynamics, and European biotech ecosystems. Episodes frequently center on venture models, drug development strategies, vaccine and immunotherapy advances, and the evolving intersection of science, entrepreneurship, and capital. Noteworthy is the show's blend of practical founder stories with sharp observations about market dynamics, cross-border collaboration, and European leadership in life sciences, making it a solid listen for biotech executives, investors, and researchers curious about how to move science from lab to market.

Where can I find podcast stats for Flot.bio x Philip Hemme?

Rephonic provides a wide range of podcast stats for Flot.bio x Philip Hemme. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Flot.bio x Philip Hemme and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Flot.bio x Philip Hemme get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Flot.bio x Philip Hemme, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Flot.bio x Philip Hemme?

Rephonic provides comprehensive predictive audience data for Flot.bio x Philip Hemme, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Flot.bio x Philip Hemme have?

To see how many followers or subscribers Flot.bio x Philip Hemme has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Flot.bio x Philip Hemme?

These podcasts share a similar audience with Flot.bio x Philip Hemme:

1. The Readout Loud
2. OMR Podcast
3. The Rest Is Politics
4. BioSpace
5. All-In with Chamath, Jason, Sacks & Friedberg

How many episodes of Flot.bio x Philip Hemme are there?

Flot.bio x Philip Hemme launched 3 years ago and published 61 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Flot.bio x Philip Hemme?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Flot.bio x Philip Hemme?

Rephonic pulls ratings and reviews for Flot.bio x Philip Hemme from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Flot.bio x Philip Hemme?

Rephonic provides full transcripts for episodes of Flot.bio x Philip Hemme. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Flot.bio x Philip Hemme?

Recent guests on Flot.bio x Philip Hemme include:

1. Christian Angermayer
2. Pierre d'Epenoux
3. Jean-François Brepson
4. Hervé Hoppenot
5. Christoph Lengauer
6. Sander van Deventer
7. Pedro (Immunethep)
8. Bruno (Immunethep)

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days